Drugs / ENSO 16
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT05457400 Comparator | Apr → Jun 2022 | hypoglycemia | Alpha Republic GmbH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ENSO 16 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05457400 ↗ |
| Route | Oral | “30 g of ENSO 16 or 30 g glucose will be orally administered” NCT05457400 ↗ |